Sonoma Pharmaceuticals (SNOA) director receives 10,000-share stock option grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Sonoma Pharmaceuticals, Inc. director John McLaughlin received a grant of stock options for 10,000 shares of common stock at an exercise price of $1.26 per share. The options vest in three equal installments on July 9, 2027, July 9, 2028, and July 9, 2029, or upon a change of control. Following this award, he holds stock options covering 30,001 shares directly.
Positive
- None.
Negative
- None.
Insights
Director received routine stock option grant as board compensation.
Director John McLaughlin was granted stock options for 10,000 shares of Sonoma Pharmaceuticals common stock at an exercise price of $1.26 per share. The award is described as compensation for services on the Board of Directors, indicating a standard equity-based fee structure rather than an open-market transaction.
The options vest one-third on July 9, 2027, one-third on July 9, 2028, and one-third on July 9, 2029, or upon a change of control. This multi-year vesting schedule ties a portion of the director's compensation to longer-term company performance and continued service. After the grant, McLaughlin holds options on 30,001 shares, providing meaningful but not outsized equity exposure.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
MCLAUGHLIN JOHN
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock option (right to buy) | 10,000 | $0.00 | -- |
Holdings After Transaction:
Stock option (right to buy) — 30,001 shares (Direct, null)
Footnotes (1)
- The options vest one third each on 7/9/2027, 7/9/2028 and 7/9/2029, or upon change of control. The options were awarded and granted to Mr. McLaughlin for services performed on the Board of Directors.
Key Figures
Options granted: 10,000 shares
Exercise price: $1.26 per share
Total options after grant: 30,001 shares
+2 more
5 metrics
Options granted
10,000 shares
Stock options for common stock granted to director John McLaughlin
Exercise price
$1.26 per share
Conversion or exercise price of newly granted stock options
Total options after grant
30,001 shares
Total stock options held by John McLaughlin following the reported grant
Option expiration date
July 9, 2036
Expiration date of the granted stock options
Vesting start date
July 9, 2027
First one-third tranche of options vests on this date
Key Terms
Stock option, exercise price, change of control, Board of Directors
4 terms
Stock option financial
"Stock option (right to buy)"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price": "1.2600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
change of control financial
"vest one third each on 7/9/2027, 7/9/2028 and 7/9/2029, or upon change of control"
A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.
Board of Directors financial
"granted to Mr. McLaughlin for services performed on the Board of Directors"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
FAQ
What did Sonoma Pharmaceuticals (SNOA) director John McLaughlin report in this Form 4?
Director John McLaughlin reported a grant of stock options for 10,000 shares of Sonoma Pharmaceuticals common stock, awarded as compensation for his services on the Board of Directors.
What is the exercise price of the stock options granted to John McLaughlin at SNOA?
The stock options granted to John McLaughlin have an exercise price of $1.26 per share, allowing him to buy Sonoma Pharmaceuticals common stock at that price once the options vest.
How do the new Sonoma Pharmaceuticals (SNOA) options granted to John McLaughlin vest?
The options vest in three equal installments: one third on July 9, 2027, one third on July 9, 2028, and one third on July 9, 2029, or upon a change of control.
What is the total stock option position John McLaughlin holds in SNOA after this grant?
Following the grant, John McLaughlin holds stock options covering 30,001 shares of Sonoma Pharmaceuticals common stock, all reported as direct ownership in this Form 4 filing.
When do the newly granted Sonoma Pharmaceuticals (SNOA) options to John McLaughlin expire?
The stock options granted to John McLaughlin expire on July 9, 2036, giving him a long-term window to exercise the right to buy Sonoma Pharmaceuticals common stock.
Why were the Sonoma Pharmaceuticals (SNOA) stock options granted to John McLaughlin?
The filing states the options were awarded and granted to John McLaughlin for services performed on the Board of Directors, indicating they are part of his director compensation.